The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes
Abstract
OBJECTIVE—To test the hypothesis that enzymes conventionally associated with liver dysfunction (aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase [GGT], and alkaline phosphatase) may predict diabetes. RESEARCH DESIGN AND METHODS—From a population-based diabetes survey, we selected 1,441 men and women in whom serum enzyme levels were ≤3 SDs of the mean population value, alcohol intake was <250 g/week, and hepatitis B and C virus testing was negative. At follow-up (7 years), 94 subjects developed diabetes and 93 impaired glucose tolerance (IGT). RESULTS—At baseline, all four enzymes were related to most of the features of the metabolic syndrome. After controlling for sex, age, adiposity/fat distribution, alcohol intake, serum lipids, and blood pressure, higher alanine aminotransferase and GGT values were significantly (P < 0.01) associated with both IGT and diabetes, whereas alkaline phosphatase was associated with diabetes only (P = 0.0004) and aspartate aminotransferase with IGT only (P = 0.0001). Raised GGT alone was associated with all the features of the metabolic syndrome. Raised GGT was a significant predictor of either IGT or diabetes (odds ratio 1.62 [95% CI 1.08–2.42] top quartile vs. lower quartiles, P < 0.02) after controlling for sex, age, adiposity/fat distribution, alcohol consumption, fasting plasma insulin and proinsulin levels, and 2-h postglucose plasma glucose concentrations. CONCLUSIONS—Although mild elevations in liver enzymes are associated with features of the metabolic syndrome, only raised GGT is an independent predictor of deterioration of glucose tolerance to IGT or diabetes. As GGT signals oxidative stress, the association with diabetes may reflect both hepatic steatosis and enhanced oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Self-citationLudwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · cited 8×
“Concentrations of serum aminotransferase close to the upper limit of the normal range, but still within the normal range (in the absence of hepatitis virus infection or heavy alcohol consumption), have been related to NAFLD, or nonalcoholic steato-hepatitis (22,23).”
BackgroundResultInfluentialPowell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Radicals and oxidative stress in diabetes
West, I. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00259.x · Cited by 913
NILSSEN, O., FØRDE, O. H., & BRENN, T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115661 · Cited by 815
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717
Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 501
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Self-citationNon-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance
James, O. F. W., & Day, C. P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80073-1 · Cited by 373
Gamma-glutamyltransferase and diabetes—a 4 year follow-up study
Lee, D.-H., Ha, M.-H., Kim, J.-H., Christiani, D. C., Gross, M. D., Steffes, M., Blomhoff, R., & Jacobs, D. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1036-5 · Cited by 344
Wannamethee, G., Ebrahim, S., & Gerald Shaper, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117699 · Cited by 334
Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM
Perry, I. J., Wannamethee, S. G., & Shaper, A. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.732 · Cited by 319
Ohlson, L.-O., Larsson, B., Bj�rntorp, P., Eriksson, H., Sv�rdsudd, K., Welin, L., Tibblin, G., & Wilhelmsen, L. (1988) · Diabetologia · doi:10.1007/bf00277480 · Cited by 316
Non‐alcoholic steatohepatitis: another disease of affluence
James, *., & Day, C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00163-4 · Cited by 271 · cited 1×
“Concentrations of serum aminotransferase close to the upper limit of the normal range, but still within the normal range (in the absence of hepatitis virus infection or heavy alcohol consumption), have been related to NAFLD, or nonalcoholic steato-hepatitis (22,23).”
BackgroundREVIEW: Nonalcoholic steatohepatitis
LUDWIG, J., McGILL, D. B., & LINDOR, K. D. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00450.x · Cited by 248
Reaven, G. M. (1994) · PubMed · Cited by 241
Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue.
Hanigan, M. H., & Frierson, H. F. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.10.8813074 · Cited by 208
Nonalcoholic Steatohepatitis in Obesity: A Reversible Condition
ERIKSSON, S., ERIKSSON, K., & BONDESSON, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02733.x · Cited by 198
Banerji, M. A., Buckley, M.-C., Chaiken, R. L., Gordon, D., Lebovitz, H. E., & Kral, J. G. (1995) · PubMed · Cited by 180
Expression of γ-Glutamyl Transpeptidase Protects Ramos B Cells from Oxidation-induced Cell Death
Karp, D. R., Shimooku, K., & Lipsky, P. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008484200 · Cited by 179
Genetic and Environmental Determinants of Type II Diabetes in Mexico City and San Antonio
Stern, M. P., Gonzalez, C., Mitchell, B. D., Villalpando, E., Haffner, S. M., & Hazuda, H. P. (1992) · Diabetes · doi:10.2337/diab.41.4.484 · Cited by 178
Self-citationDrożdż, R., Parmentier, C., Hachad, H., Leroy, P., Siest, G., & Wellman, M. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00127-0 · Cited by 151
Goto, T., Onuma, T., Takebe, K., & Kral, J. G. (1995) · PubMed · Cited by 145
Robinson, D., & Whitehead, T. P. (1989) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328902600503 · Cited by 113
Arnesen, E., Huseby, N., Brenn, T., & Try, K. (1986) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518609086483 · Cited by 97
Erbey, J. R., Silberman, C., & LYDICK, E. G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00602-1 · Cited by 95
Haffner, S. M., González-Bonilla, C. R., Mykkänen, L., & Stern, M. P. (1997) · Diabetologia · doi:10.1007/s001250050756 · Cited by 85
Self-citationMeltzer, A. A., & Everhart, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009315 · Cited by 66
Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years.
Steffensen, F. H., Sørensen, H. T., Brock, A., Vilstrup, H., & Lauritzen, T. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.1.92 · Cited by 60
Glucose intolerance and serum aminotransferase activities in Japanese men
Miyake, Y., Eguchi, H., Shinchi, K., Oda, T., Sasazuki, S., & Kono, S. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00323-9 · Cited by 25
Cited by
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13264 · Cited by 717
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation
Mohamed, J., H., N. N. A., H., Z. A., & B., B. S. (2016) · Sultan Qaboos University Medical Journal · doi:10.18295/squmj.2016.16.02.002 · Cited by 473
Metadata
- Authors
- Nannipieri, M., Gonzales, C., Baldi, S., Posadas, R., Williams, K., Haffner, S. M., Stern, M. P., & Ferrannini, E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-07-01
- Volume
- 28
- Issue
- 7
- Pages
- 1757-1762
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2181441354
- Cited by
- 308
- References
- 34
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.